These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Medical adjuvant treatment to increase patency of arteriovenous fistulae and grafts. Mohamed I; Kamarizan MFA; Da Silva A Cochrane Database Syst Rev; 2021 Jul; 7(7):CD002786. PubMed ID: 34298589 [TBL] [Abstract][Full Text] [Related]
6. Effects of low dose aspirin (50 mg/day), low dose aspirin plus dipyridamole, and oral anticoagulant agents after internal mammary artery bypass grafting: patency and clinical outcome at 1 year. CABADAS Research Group of the Interuniversity Cardiology Institute of The Netherlands. Prevention of Coronary Artery Bypass Graft Occlusion by Aspirin, Dipyridamole and Acenocoumarol/Phenprocoumon Study. van der Meer J; Brutel de la Rivière A; van Gilst WH; Hillege HL; Pfisterer M; Kootstra GJ; Dunselman PH; Mulder BJ; Lie KI J Am Coll Cardiol; 1994 Nov; 24(5):1181-8. PubMed ID: 7930237 [TBL] [Abstract][Full Text] [Related]
7. Medical adjuvant treatment to increase patency of arteriovenous fistulae and grafts. Tanner NC; Da Silva A Cochrane Database Syst Rev; 2015 Jul; 2015(7):CD002786. PubMed ID: 26184395 [TBL] [Abstract][Full Text] [Related]
8. Dipyridamole plus aspirin and hemodialysis graft patency. Hentschel DM N Engl J Med; 2009 Aug; 361(7):720-1; author reply 721. PubMed ID: 19681176 [No Abstract] [Full Text] [Related]
9. Effects of antiplatelet therapy with indobufen or aspirin-dipyridamole on graft patency one year after coronary artery bypass grafting. Rajah SM; Nair U; Rees M; Saunders N; Walker D; Williams G; Critchley A; Beton D; Campbell C; Lawson RA J Thorac Cardiovasc Surg; 1994 Apr; 107(4):1146-53. PubMed ID: 8159037 [TBL] [Abstract][Full Text] [Related]
10. Antiplatelet drugs in femoropopliteal vein bypasses: a multicenter trial. McCollum C; Alexander C; Kenchington G; Franks PJ; Greenhalgh R J Vasc Surg; 1991 Jan; 13(1):150-61; discussion 161-2. PubMed ID: 1987387 [TBL] [Abstract][Full Text] [Related]
11. Anti-platelet therapy in graft thrombosis: results of a prospective, randomized, double-blind study. Sreedhara R; Himmelfarb J; Lazarus JM; Hakim RM Kidney Int; 1994 May; 45(5):1477-83. PubMed ID: 8072261 [TBL] [Abstract][Full Text] [Related]
12. Dipyridamole plus aspirin and hemodialysis graft patency. Weale AR; Cooper DG N Engl J Med; 2009 Aug; 361(7):720; author reply 721. PubMed ID: 19675337 [No Abstract] [Full Text] [Related]
13. Antiplatelet therapy and vascular-access patency. Lok CE N Engl J Med; 2009 May; 360(21):2240-2. PubMed ID: 19458370 [No Abstract] [Full Text] [Related]
14. Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke. Sacco RL; Diener HC; Yusuf S; Cotton D; Ounpuu S; Lawton WA; Palesch Y; Martin RH; Albers GW; Bath P; Bornstein N; Chan BP; Chen ST; Cunha L; Dahlöf B; De Keyser J; Donnan GA; Estol C; Gorelick P; Gu V; Hermansson K; Hilbrich L; Kaste M; Lu C; Machnig T; Pais P; Roberts R; Skvortsova V; Teal P; Toni D; Vandermaelen C; Voigt T; Weber M; Yoon BW; N Engl J Med; 2008 Sep; 359(12):1238-51. PubMed ID: 18753638 [TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of antiplatelet therapy to prolong primary patency of hemodialysis graft. Nee R; Parker AL; Little DJ; Yuan CM; Himmelfarb J; Lowe SR; Abbott KC Clin Nephrol; 2014 Jan; 81(1):38-51. PubMed ID: 24161074 [TBL] [Abstract][Full Text] [Related]
16. Prevention of one-year vein-graft occlusion after aortocoronary-bypass surgery: a comparison of low-dose aspirin, low-dose aspirin plus dipyridamole, and oral anticoagulants. The CABADAS Research Group of the Interuniversity Cardiology Institute of The Netherlands. van der Meer J; Hillege HL; Kootstra GJ; Ascoop CA; Mulder BJ; Pfisterer M; van Gilst WH; Lie KI Lancet; 1993 Jul; 342(8866):257-64. PubMed ID: 8101300 [TBL] [Abstract][Full Text] [Related]
17. Indobufen compared with aspirin and dipyridamole on graft patency after coronary artery bypass surgery: results of a combined analysis. Cataldo G; Heiman F; Lavezzari M; Marubini E Coron Artery Dis; 1998; 9(4):217-22. PubMed ID: 9649928 [TBL] [Abstract][Full Text] [Related]
18. Clinical effectiveness and cost-effectiveness of clopidogrel and modified-release dipyridamole in the secondary prevention of occlusive vascular events: a systematic review and economic evaluation. Jones L; Griffin S; Palmer S; Main C; Orton V; Sculpher M; Sudlow C; Henderson R; Hawkins N; Riemsma R Health Technol Assess; 2004 Oct; 8(38):iii-iv, 1-196. PubMed ID: 15461876 [TBL] [Abstract][Full Text] [Related]
19. Effect of low dose aspirin and dipyridamole on primary patency of arteriovenous grafts in hemodialysis patients: a randomized double-blind placebo-controlled trial. Tayebi P; Kazemzadeh G; Banihashem A; Ravari H Electron Physician; 2018 Jan; 10(1):6135-6139. PubMed ID: 29588811 [TBL] [Abstract][Full Text] [Related]
20. The Japanese aggrenox (extended-release dipyridamole plus aspirin) stroke prevention versus aspirin programme (JASAP) study: a randomized, double-blind, controlled trial. Uchiyama S; Ikeda Y; Urano Y; Horie Y; Yamaguchi T Cerebrovasc Dis; 2011; 31(6):601-13. PubMed ID: 21502757 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]